% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ranger43a ranger43a Nov 25, 2012 12:00 PM Flag

    Hsp 90 Inhibitor

    Actually, not true.
    Infinity Pharmaceuticals (INFI) has an Hsp90 inhibitor-- Retaspimycin HCL. Theirs targets similar cancer patient populations as Synta's. But their market cap is double that of Synta's!!! (in part, they do have a second very promising drug, IPI-145). Synta is still quite UNDER-valued, and has a lot of room to run. Look at Infinity's yearly chart. I predict that will be our chart as well in 2013....

0.3606-0.0194(-5.11%)May 26 4:00 PMEDT